Title: Amélie Royet: Innovator in Cancer Treatment Research
Introduction
Amélie Royet is an inventor based in Mornant, France. He has made significant contributions to the field of cancer treatment research. Although he currently holds no granted patents, his work is focused on developing innovative solutions for combating various types of cancer.
Latest Patent Applications
Amélie Royet's latest patent application is titled "Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents." This invention pertains to the treatment of certain cancers using antagonists that inhibit the binding between Plexin and Sema3E. The application highlights the potential for treating primary cancer cell development and metastasis, particularly in cases where Sema3E is overexpressed by tumoral cells or the stroma. The invention addresses several types of cancer, including breast cancer with distant metastases, prostate cancer, melanoma, and glioblastoma. The proposed antagonists may include any molecule that specifically binds to PlexinD1 or Sema3E, effectively blocking their interaction. In some embodiments, these antagonists may be polypeptides or antibodies.
Conclusion
Amélie Royet is a dedicated inventor whose research focuses on innovative cancer treatment strategies. His work has the potential to significantly impact the field of oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.